The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of first-line therapy with novel agents in multiple myeloma patients age 80 and above: A systematic review.
 
Sadaf Rahman
No Relationships to Disclose
 
Cody Sider
No Relationships to Disclose
 
Fadi Bahodi
No Relationships to Disclose
 
Selay Lam
Honoraria - Abbvie; Alexion Pharmaceuticals; Amgen; AstraZeneca; Bayer; Celgene; Gilead Sciences; Janssen; Novartis; Paladin; Pfizer; Roche; Seagen; Takeda
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Amgen; AstraZeneca; Bayer; Celgene; Gilead Sciences; Janssen; Novartis; Paladin; Pfizer; Roche; Seagen; Takeda
Research Funding - AstraZeneca; Janssen; Seagen
 
Martha Louzada
Honoraria - Amgen; Celgene; Janssen; Pfizer
Consulting or Advisory Role - Amgen; Celgene; Janssen
 
Chai W. Phua
Honoraria - Amgen; AstraZeneca; Bayer; Bioverativ/Sanofi; Bristol-Myers Squibb/Celgene; Novartis; Novo Nordisk; Pfizer; Roche; Shire/Takeda; Teva
Consulting or Advisory Role - Amgen; Bioverativ/Sanofi; Bristol-Myers Squibb/Celgene; Pfizer; Roche; Shire/Takeda
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb/Celgene; Gilead Sciences; Novo Nordisk; Octapharm; Pfizer; Shire/Takeda